Ocular manifestations of occupational exposure to corticosteroids in the pharmaceutical industry

WIT Transactions on Biomedicine and Health

Volumn 10, Issue , 2006, Pages 145-155

  Metwally, F M ^a   El Assal, S ^b   Kamel, E A ^c  

^a NATIONAL RESEARCH CENTRE   (Egypt)

^b MINISTRY OF HEALTH   (Egypt)

^c MANSOURA UNIVERSITY   (Egypt)

Author keywords

Cataracts; Corticosteroid; Diabetes mellitus; Glaucoma; Hypertension; Lipid profile, pharmaceutical; Occupational; Ocular hypertension; Ocular manifestations

Indexed keywords

BIOCHEMISTRY; CHOLESTEROL; DIAGNOSIS; DRUG PRODUCTS; HORMONES; PARAMETER ESTIMATION;

DIABETES MELLITUS; OCULAR HYPERTENSION; OCULAR MANIFESTATIONS; PHARMACEUTICAL INDUSTRY;

DISEASES;

EID: 36148956768     PISSN: 17433525     EISSN: None     Source Type: Conference Proceeding    
DOI: 10.2495/ETOX060151     Document Type: Article

References (13)

1. Carnahan MC, and Goldstein DA. Ocular complications of topical, periocular, & systemic corticosteroids. Curr Opin Ophthalmol 2000; 11(6):478-483.
2. Davies DS. Pharmacokinetics of inhaled substances. Post-grad Med j 1975; 51 (Suppl 7): 69-75.
3. Dryer EB. Inhaled steroid use and glaucoma 'letter'. N Engl J Med 1933; 329:1822.
4. Fraunfelder FT, and Meyer SM. Posterior subcapsular cataracts associated with nasal or inhalation corticosteroids. Am J Ophthalmol 1990; 109: 489-490.
5. Garbe E, Suissa S, and LeLorier J. Association of inhaled corticosteroids with cataract extraction in elderly patients. JAMA 1998; 280: 539- 543.
6. Haimovici R, Gragoudas ES, Duker JS, Sjaarda RN, and Eliott D. Central serous chorioretinopathy associated with inhaled or intranasal corticosteroids. Ophthalmology 1997; 104 (10): 1653-1660.
7. Khan HA, Leibowitz HM, and Ganley JP. The Framingham Eye Study: Outline and major prevalence findings. Am J Epidemiol 1977; 106: 17-27.
8. Leske MC, Chylack LT, and Wu SY. The lens opacities - case control study. Risk factors for cataract. Arch Ophthalmol 1991; 109: 244.
9. Mitchell P, Cumming RG, and Mackey DA. Inhaled corticosteroids, family history, and risk of glaucoma. Ophthalmology 1999; 106 (12): 2301-2306.
10. Newman SP, Moren F, & Pavia D. Deposition of pressure suspension aerosols inhaled through extension devices. Am Rev Respir Dis 1981;124: 317-320.
11. Opatowsky I, Feldman RM, Gross R, and Feldman ST. Introcular pressure elevation associated with inhalation and nasal corticosteroids. Ophthalmology 1995; 102 (20): 177-179.
12. thed. Rockville, MD: US Pharmacopeial Convention 1992; 56- 62.
13. West SK. Editorial: who develops cataracts? Arch Ophthalmol 1991; 109: 196.